The largest database of trusted experimental protocols

3 protocols using biotinylated donkey anti sheep antibody

1

Dual Immunofluorescence Staining for GLP-1R and GFRAL

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sections were dewaxed, hydrated, and incubated in 0.1% pronase in TBS-T buffer for 10 min. Sections were then blocked with avidin-biotin (004303, Thermo Fisher Scientific, Waltham, MA) prior to incubation with 5 μg/ml rabbit anti-GLP-1R antibody (7F38, Novo Nordisk A/S, Denmark) for 1 h at RT. Following washing in TBS-T, sections were incubated with biotinylated donkey anti-rabbit antibody (1:200, 711-165-152, Jackson ImmunoResearch, Cambridgeshire, UK) for 30 min. Sections were washed in TBS-T and signal amplification was performed with ABC elite kit (PK6100, Vector Laboratories, Burlingame, CA) followed by incubation in 1:50 TSA-Flourscein-Cy2 (SAT701001EA, Perkin Elmer, Waltham, MA) for 40 min. Next, the sections were incubated in TEG buffer (pH 9.0) for 15 min, washed in TBS-T, blocked with avidin-biotin, and incubated in TNB for 30 min prior to incubation with 0.2 mg/ml sheep-anti GFRAL antibody (PA547769, Thermo Fisher Scientific) over night at 4 °C. Following washing in TBS-T, sections were incubated in 1:1000 biotinylated donkey anti-sheep antibody (713-065-147, Jackson Immuno Research) for 30 min at RT. Signal amplification was performed with 1:100 TSA Tyramide-Cy3 (SAT704A001EA, Perkin Elmer). Sections were washed in dH2O and mounted with fluorescent mounting media (S3023, Dako). Confocal images were acquired using the Leica Confocal Imaging System TCS SP8.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of MUC1 in COVID-19 Lung Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry with MUC1 was performed on formalin-fixed paraffin-embedded human lung tissue from either autopsied COVID-19 patients or from biopsied lung tissue from patients with COVID-19. Lung tissue collected as paired control tissue of patients with lung cancer served as the control. Briefly, tissue sections of 5 μm thickness were mounted on glass slides (Superfrost, Thermo Fisher Scientific), deparaffinized, and boiled in citrate buffer (pH 6) and incubated overnight with anti–Muc-1 antibody (sheep pAb, AF6298, R&D Systems, 1:500) at 4°C. Primary antibody was detected by biotinylated donkey anti-sheep antibody (Jackson ImmunoResearch, 1:200) combined with HRP-conjugated Extravidin (Sigma-Aldrich) and developed with 5′, 5′ diaminobenzidine (DAKO, Agilent Technologies). Slides were counterstained with hematoxylin and visualized by Zeiss Scope A1 as described previously (48 (link)).
+ Open protocol
+ Expand
3

Visualizing CLIC1 and RhoA in BMDCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Resting BMDCs or BMDCs 5 min after initiation of synchronised phagocytosis were fixed with 4% paraformaldehyde (Cat #C004, ProSciTech) on 8-chamber slides (Cat #354108, BD Biosciences), then permeabilised with 0.05% saponin (Cat #S4521, Sigma-Aldrich) (Jiang et al., 2012 (link)). After blocking with 2% IgG free BSA (Cat #001-000-161, Jackson ImmunoResearch Labs) and 1 µg/ml Fc receptor blocking antibody (Cat #553142, BD Biosciences), the cells were stained for; CLIC1 and RhoA. Briefly, BMDCs were firstly stained with 1:100 rabbit anti-mouse RhoA antibody then 1:100 donkey anti-rabbit Cy2 antibody (Cat#ab6940, Abcam) followed by an in-house-derived 1:1000 sheep anti-mouse CLIC1 (Jiang et al., 2012 (link)), then 1:100 biotinylated donkey anti-sheep antibody (Cat #713-065-003, Jackson ImmunoResearch Labs) and finally streptavidin Cy3 (Cat#S6402, Sigma-Aldrich) (Jiang et al., 2012 (link)). Confocal images were obtained on a Leica TCS SP confocal microscope (Leica Microsystems, Germany) and processed using ImageJ64 (NIH, imagej.nih.gov/ij/download/).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!